These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6105793)

  • 21. [Tardive dyskinesia and affective disorders].
    Azorin JM; Thermoz P
    Encephale; 1988; 14(5):359-63. PubMed ID: 2905642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive dyskinesia.
    McAfee HA
    Am J Nurs; 1978 Mar; 78(3):359-7. PubMed ID: 25020
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia.
    Bsoul SA; Terezhalmy GT; Riley CK; Moore WS
    Quintessence Int; 2002 Apr; 33(4):326-7. PubMed ID: 11989382
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Int Rev Neurobiol; 1979; 21():1-45. PubMed ID: 43842
    [No Abstract]   [Full Text] [Related]  

  • 27. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N; Rondot P; Koutlidis RM
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tardive dyskinesias. Epidemiology and physiopathology].
    Gerlach J
    Ugeskr Laeger; 1987 Jun; 149(25):1678-81. PubMed ID: 2885954
    [No Abstract]   [Full Text] [Related]  

  • 29. Receptors, neurotransmitters and drug responses.
    Snyder SH
    N Engl J Med; 1979 Mar; 300(9):465-72. PubMed ID: 32488
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine antagonist and agonist treatment of tardive dyskinesia.
    Bjørndal N; Casey D; Gerlach J
    Adv Biochem Psychopharmacol; 1980; 24():541-5. PubMed ID: 6105800
    [No Abstract]   [Full Text] [Related]  

  • 31. Case report of adverse effect of reserpine on tardive dyskinesia.
    Donatelli A; Geisen L; Feuer E
    Am J Psychiatry; 1983 Feb; 140(2):239-40. PubMed ID: 6129810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes.
    Seeman P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):3S-9S. PubMed ID: 2906067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
    Olajossy M
    Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms underlying tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():433-46. PubMed ID: 826999
    [No Abstract]   [Full Text] [Related]  

  • 36. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-onset akathisia--an indicant of covert dyskinesia: two case reports.
    Braude WM; Barnes TR
    Am J Psychiatry; 1983 May; 140(5):611-2. PubMed ID: 6133460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 39. Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"?
    Kapit RM
    Med Hypotheses; 1977; 3(5):207-10. PubMed ID: 904502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.